PHARMACOKINETICS OF INTRAVENOUS CEFETAMET (RO 15-8074) AND ORAL CEFETAMET PIVOXIL (RO 15-8075) IN YOUNG AND ELDERLY SUBJECTS

被引:31
作者
BLOUIN, RA
KNEER, J
STOECKEL, K
机构
[1] F HOFFMANN LA ROCHE & CO LTD,DEPT CLIN RES,CH-4002 BASEL,SWITZERLAND
[2] UNIV KENTUCKY,COLL PHARM,LEXINGTON,KY 40536
关键词
D O I
10.1128/AAC.33.3.291
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:291 / 296
页数:6
相关论文
共 11 条
  • [1] CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS
    BALANT, L
    DAYER, P
    AUCKENTHALER, R
    [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (02) : 101 - 143
  • [2] BERMAN PM, 1972, GERIATRICS, V27, P84
  • [3] Gibaldi M., 1982, PHARMACOKINETICS, P445
  • [4] PHARMACOKINETICS OF CEFETAMET (RO-15-8074) AND CEFETAMET PIVOXIL (RO-15-8075) AFTER INTRAVENOUS AND ORAL DOSES IN HUMANS
    KOUP, JR
    DUBACH, UC
    BRANDT, R
    WYSS, R
    STOECKEL, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) : 573 - 579
  • [5] LEA CS, 1980, J PHARMACOKINET BIOP, V8, P335
  • [6] AGING AND RENAL CLEARANCE OF PROCAINAMIDE AND ACETYLPROCAINAMIDE
    REIDENBERG, MM
    CAMACHO, M
    KLUGER, J
    DRAYER, DE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) : 732 - 735
  • [7] EFFECT OF AGE ON CREATININE CLEARANCE IN MEN - CROSS-SECTIONAL AND LONGITUDINAL STUDY
    ROWE, JW
    ANDRES, R
    TOBIN, JD
    NORRIS, AH
    SHOCK, NW
    [J]. JOURNALS OF GERONTOLOGY, 1976, 31 (02): : 155 - 163
  • [8] AGING OR DISEASE
    WILLIAMS, TF
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (06) : 663 - 665
  • [9] INVITRO ACTIVITY OF RO 15-8074 AND RO 19-5247, 2 ORALLY-ADMINISTERED CEPHALOSPORIN METABOLITES
    WISE, R
    ANDREWS, JM
    PIDDOCK, LJV
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) : 1067 - 1072
  • [10] DETERMINATION OF CEFETAMET AND ITS ORALLY ACTIVE ESTER, CEFETAMET PIVOXYL, IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    WYSS, R
    BUCHELI, F
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 430 (01): : 81 - 92